Kamada Ltd.
General ticker "KMDA" information:
- Sector: Health Care
- Industry: Drug Manufacturers - Specialty & Generic
- Capitalization: $419.8M (TTM average)
Kamada Ltd. follows the US Stock Market performance with the rate: 37.8%.
Estimated limits based on current volatility of 1.3%: low 7.47$, high 7.68$
Factors to consider:
- Company pays dividends (irregularly): last record date 2026-03-23, amount 0.25$ (Y3.38%)
- Total employees count: 289 as of 2013
- Price in estimated range
- Earnings for 3 months up through Q1 exceed our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2025-12-31 to 2027-12-31
- 2025-12-31 to 2026-12-31 estimated range: [5.74$, 8.64$]
- 2026-12-31 to 2027-12-31 estimated range: [6.28$, 9.36$]
Financial Metrics affecting the KMDA estimates:
- Positive: with PPE of 20.3 at the end of fiscal year the price was very low
- Positive: 7.54 < Operating profit margin, % of 14.54
- Positive: 6.59 < Operating cash flow per share per price, % of 6.74
- Positive: 1.81 < Return on assets ratio (scaled to [-100,100]) of 5.06
- Positive: Shareholder equity ratio, % of 71.05 > 64.29
- Positive: Interest expense per share per price, % of 0.21 <= 0.73
- Negative: negative Industry operating cash flow (median)
Short-term KMDA quotes
Long-term KMDA plot with estimates
Financial data
| YTD | 2023-12-31 | 2024-12-31 | 2025-12-31 |
|---|---|---|---|
| Operating Revenue | $142.52MM | $160.95MM | $180.46MM |
| Operating Expenses | $132.46MM | $140.90MM | $154.23MM |
| Operating Income | $10.06MM | $20.05MM | $26.23MM |
| Non-Operating Income | $-1.64MM | $-6.72MM | $-2.77MM |
| Interest Expense | $1.30MM | $0.66MM | $0.86MM |
| R&D Expense | $13.93MM | $15.19MM | $12.99MM |
| Income(Loss) | $8.43MM | $13.33MM | $23.47MM |
| Taxes | $0.14MM | $-1.13MM | $3.27MM |
| Net Income(Loss)* | $8.28MM | $14.46MM | $21.86MM |
| Stockholders Equity | $244.02MM | $259.46MM | $269.13MM |
| Inventory | $88.48MM | $78.82MM | $84.96MM |
| Assets | $354.91MM | $372.25MM | $378.79MM |
| Operating Cash Flow | $4.32MM | $47.59MM | $27.59MM |
| Capital expenditure | $5.85MM | $10.74MM | $10.66MM |
| Investing Cash Flow | $-5.84MM | $-10.74MM | $-10.65MM |
| Financing Cash Flow | $22.68MM | $-13.91MM | $-19.86MM |
| Earnings Per Share** | $0.17 | $0.25 | $0.38 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.